© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Green Thumb Industries Inc. (GTBIF) stock declined over -0.30%, trading at $6.70 on OTC, down from the previous close of $6.72. The stock opened at $6.60, fluctuating between $6.60 and $6.85 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Feb 03, 2026 | 6.60 | 6.85 | 6.60 | 6.70 | 318.38K |
| Feb 02, 2026 | 6.84 | 7.15 | 6.51 | 6.72 | 297.03K |
| Jan 30, 2026 | 6.82 | 7.17 | 6.66 | 6.66 | 369.76K |
| Jan 29, 2026 | 7.25 | 7.25 | 6.71 | 6.87 | 666.23K |
| Jan 28, 2026 | 7.32 | 7.56 | 7.10 | 7.18 | 439.1K |
| Jan 27, 2026 | 7.60 | 7.72 | 7.25 | 7.28 | 384.26K |
| Jan 26, 2026 | 7.89 | 7.98 | 7.55 | 7.55 | 643.54K |
| Jan 23, 2026 | 7.98 | 8.17 | 7.85 | 8.06 | 310.96K |
| Jan 22, 2026 | 7.90 | 8.02 | 7.70 | 7.95 | 236.41K |
| Jan 21, 2026 | 7.90 | 7.97 | 7.65 | 7.73 | 248.15K |
| Jan 20, 2026 | 8.09 | 8.09 | 7.80 | 7.80 | 471.26K |
| Jan 16, 2026 | 8.30 | 8.41 | 8.00 | 8.10 | 225.7K |
| Jan 15, 2026 | 8.45 | 8.64 | 8.27 | 8.35 | 159.92K |
| Jan 14, 2026 | 8.40 | 8.84 | 8.25 | 8.36 | 162.68K |
| Jan 13, 2026 | 8.76 | 8.79 | 8.39 | 8.40 | 178.67K |
| Jan 12, 2026 | 8.40 | 8.93 | 8.02 | 8.77 | 415.88K |
| Jan 09, 2026 | 8.14 | 8.30 | 7.98 | 8.10 | 304.86K |
| Jan 08, 2026 | 8.20 | 8.49 | 8.05 | 8.22 | 535.92K |
| Jan 07, 2026 | 8.00 | 8.23 | 7.96 | 8.17 | 345.59K |
| Jan 06, 2026 | 7.77 | 8.15 | 7.69 | 8.00 | 504.31K |
Green Thumb Industries Inc. engages in manufacture, distribution, and sale of various cannabis products for medical and adult-use in the United States. It offers cannabis flower; and processed and packaged products, including pre-rolls, concentrates, vapes, tinctures, edibles, topicals, and other cannabis-related products under the Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands. The company distributes its products primarily to third-party retail stores, as well as sells finished products directly to consumers in its own retail stores. As of April 11, 2022, it owned and operated 77 retail stores in the United States. The company was founded in 2014 and is headquartered in Chicago, Illinois.
| Employees | 4900 |
| Beta | 0.9 |
| Sales or Revenue | $1.07B |
| 5Y Sales Change% | 8.08% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |